Publication | Closed Access

In vivo treatment with the K+ channel blocker 4-aminopyridine protects against kainate-induced neuronal cell death through activation of NMDA receptors in murine hippocampus

NeurophysiologyMedicineNmda ReceptorsNeuropharmacologyNeuroprotectionNeuroscienceNeurotransmissionVivo TreatmentMolecular NeurobiologyPharmacologyNeurochemistrySocial SciencesMurine Hippocampus